Tevogen Bio Holdings Inc. Annual Share-based Payment Arrangement, Expense in USD for 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tevogen Bio Holdings Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate for 2024.
  • Tevogen Bio Holdings Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2025 was $3.24M, a 21.8% decline year-over-year.
  • Tevogen Bio Holdings Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2025 was $20.8M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $40.8M Jan 1, 2024 Dec 31, 2024 10-K 2025-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.